Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Subst Abus ; 42(3): 366-371, 2021.
Article in English | MEDLINE | ID: mdl-32693706

ABSTRACT

BACKGROUND: In recent years, marijuana has become legal for use in many states, for either medicinal or recreational purposes. Objective: The primary objective is to determine if legalization of medical marijuana is associated with an increased use among trauma patients. Methods: Prospective observational study included three periods; (pre-legalization; period 1); legal to grow for medicinal purposes but no dispensaries open (period 2); and legal to purchase medicinal marijuana in a dispensary (period 3). The study included all adult trauma patients presenting to an urban level I trauma center in Phoenix, AZ. The prevalence of use (as defined by positive urine drug screen or self-reporting) in each time period was determined and compared using two sample tests of proportion. Confidence intervals for prevalence (self-reporting only) were compared with published age matched data from the same geographical region of the general population. Results: The prevalence of marijuana use increased significantly from pre-legalization (period 1) to post legalization (periods 2 and 3), but there was no significant change between the two post legalization periods. After controlling for age and sex, the odds of being marijuana positive post-legalization vs. pre-legalization was 1.36, p = 0.006 95%CI [1.09-1.7]. Overall, the prevalence of marijuana among trauma patients was nearly four-fold higher than the population as a whole in the same geographic region. Patients who use marijuana are more likely to use cocaine or amphetamine (OR 2.31; 95% CI 1.86-2.89) or had an ethanol level above 80 mg/dL (OR 1.57; 95% CI 1.32-1.87). Conclusion: The legalization of medicinal marijuana is associated with significantly increased prevalence among trauma patients. It appears that legalization, rather than the convenience of dispensaries, is associated with an increase in use.


Subject(s)
Marijuana Smoking , Marijuana Use , Medical Marijuana , Adult , Arizona , Humans , Marijuana Smoking/epidemiology , Marijuana Use/epidemiology , Medical Marijuana/therapeutic use , Prevalence
2.
Am J Emerg Med ; 37(1): 177.e1-177.e4, 2019 01.
Article in English | MEDLINE | ID: mdl-30314903

ABSTRACT

Optic neuritis (ON) is an inflammatory condition that causes demyelination and thickening of the optic nerve leading to acute/subacute vision loss. It is frequently associated with other conditions like multiple sclerosis, but is often misdiagnosed, which can lead to a suboptimal prognosis. Ultrasound is rarely utilized to help make this diagnosis, even though it can easily detect a thickened retrobulbar optic nerve sheath diameter. We describe four cases in which ultrasonographic measurement of the optic nerve sheath diameter aided in the diagnosis of ON.


Subject(s)
Emergency Service, Hospital , Optic Neuritis/diagnostic imaging , Point-of-Care Testing , Adult , Anti-Inflammatory Agents/therapeutic use , Female , Humans , Male , Methylprednisolone/therapeutic use , Middle Aged , Optic Neuritis/drug therapy , Photophobia/etiology , Plasma Exchange , Ultrasonography , Vision, Low/etiology
3.
Hawaii J Med Public Health ; 75(9): 273-7, 2016 09.
Article in English | MEDLINE | ID: mdl-27688953

ABSTRACT

Recovery of left ventricular (LV) function after revascularization has been described for coronary artery bypass grafting (CABG); however, LV recovery after percutaneous coronary intervention (PCI), and how it compares to CABG has not been well described in the literature. The aim of this single center retrospective study was to evaluate LV recovery in patients with severely reduced LV function undergoing PCI compared to those undergoing CABG. Patients with LV ejection fraction (LVEF) < 40% and multivessel coronary artery disease (CAD) undergoing revascularization with either CABG (n=16) or PCI (n=176), and with 12 months of follow up data were included in the study. LVEF at baseline exhibited significant differences between PCI (28.5 ± 8.0) and CABG (24.2 ± 6.8) groups (P=.05). LVEF recovery at 6-month follow up showed no difference between PCI and CABG groups. LVEF recovery differences at one-year follow-up was significantly different between PCI (4.82) and CABG (15.25) groups (P=.005). Patients with severely reduced LV function undergoing multivessel PCI had a statistically significant increase in LVEF over time; however patients undergoing CABG demonstrated greater gains in LVEF over the same time period. Surgical revascularization with CABG may be a procedure of choice in patients with depressed LV function and multivessel CAD.


Subject(s)
Coronary Artery Bypass/statistics & numerical data , Coronary Artery Disease/surgery , Outcome Assessment, Health Care/statistics & numerical data , Percutaneous Coronary Intervention/statistics & numerical data , Ventricular Dysfunction, Left/surgery , Ventricular Function, Left/physiology , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...